Sponsor Pipeline

Shanghai UniXell Biotechnology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-29 NCT07733349 Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With… Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07733349 Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With… Parkinson's Disease Not Yet Recruiting
Phase 1
NCT06778265 An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease Parkinson Disease, Idiopathic Active, Not Recruiting
NCT07572812 A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral… Epilepsy Not Yet Recruiting
Disease Areas
Parkinson's Disease (2) Epilepsy (1)
Get alerts when Shanghai UniXell Biotechnology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free